DIN 02516098 — ILUMYA 100 MG
ILUMYA is a solution of Tildrakizumab marketed by SUN PHARMACEUTICAL INDUSTRIES LIMITED. The full Tildrakizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02516098
- Brand name
- ILUMYA
- Active ingredient
- Tildrakizumab
- Strength
- 100 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES LIMITED
- Health Canada status
- MARKETED
- Drug class
- Interleukin-23 (IL-23) inhibitor (humanized monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Tildrakizumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02558904 | ILUMYA | 100 MG | SOLUTION | SUN PHARMACEUTICAL INDUSTRIES LIMITED | MARKETED |